Skip to main content
×
×
Home

Physician Perceptions Regarding Antimicrobial Use in End-of-Life Care

  • Christopher E. Gaw (a1), Keith W. Hamilton (a2), Jeffrey S. Gerber (a3) (a4) (a5) and Julia E. Szymczak (a4)
Abstract
BACKGROUND

The decision to utilize antimicrobials in end-of-life situations is complex. Understanding the reasons why physicians prescribe antimicrobials in this patient population is important for informing the design of antimicrobial stewardship interventions.

METHODS

A 51-item survey containing both closed and open-ended questions on end-of-life antimicrobial use was administered to physicians affiliated with the University of Pennsylvania and Children’s Hospital of Philadelphia from January through April 2017. A mixed-methods approach was used to analyze responses.

RESULTS

Of 637 physicians surveyed, 283 responses (44.4%) were received. Most (86.2%) physicians believed that respecting a patient’s wish to continue antimicrobials was important. Approximately half of physicians (49.8%) believed that antimicrobial use at the end of life contributes to resistance. A higher proportion of pediatricians would often or always continue antimicrobial treatment for active infections and for hospice patients whose death was imminent compared to adult physicians (P<.001). Analysis of free-text responses revealed additional reasons why physicians may continue antimicrobials at end of life, including meeting family expectations, wanting to avoid the perception of “giving up,” uncertainty about prognosis, and reducing patient pain or discomfort.

CONCLUSIONS

Physician decision making concerning antimicrobial use in patients at the end of life is multifactorial. Clinicians may overweigh the benefits of antimicrobial therapy in end-of-life situations and view the importance of adhering to stewardship policies differently. Pediatric and adult clinicians have different approaches to this patient population. Better understanding of the complex decision making that occurs in the end-of-life patient population can help guide antimicrobial stewardship policies and improve patient care.

Infect Control Hosp Epidemiol 2018;1–8

Copyright
Corresponding author
Address correspondence to Christopher E. Gaw, MD, MBE, Division of General Pediatrics, Children’s Hospital of Philadelphia, 3401 Civic Center Blvd, Philadelphia, PA 19104 (gawc@email.chop.edu).
References
Hide All
1. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention website. https://www.cdc.gov/drugresistance/threat-report-2013/index.html. Published 2013. Accessed January 10, 2018.
2. Ford PJ, Fraser TG, Davis MP, Kodish E. Anti-infective therapy at end of life: ethical decision-making in hospice-eligible patients. Bioethics 2005;19:379392.
3. Yeo JM. Antimicrobial stewardship: improving antibiotic prescribing practice in a respiratory ward. BMJ Qual Improv Rept 2016;5(1):u206491w3570.
4. Gilchrist M, Wade P, Ashiru-Oredope D, et al. Antimicrobial stewardship from policy to practice: experiences from UK antimicrobial pharmacists. Infect Dis Ther 2015;4(Suppl 1):5164.
5. Hersh AL, De Lurgio SA, Thurm C, et al. Antimicrobial stewardship programs in freestanding children’s hospitals. Pediatrics 2015;135:3339.
6. Drekonja DM, Filice GA, Greer N, et al. Antimicrobial stewardship in outpatient settings: a systematic review. Infect Control Hosp Epidemiol 2015;36:142152.
7. Fishman N. Antimicrobial stewardship. Am J Infect Control 2006;34:S55S63.
8. Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2017;2:CD003543.
9. Thompson AJ, Silveira MJ, Vitale CA, Malani PN. Antimicrobial use at the end of life among hospitalized patients with advanced cancer. Am J Hosp Palliat Care 2012;29:599603.
10. Vitetta L, Kenner D, Sali A. Bacterial infections in terminally ill hospice patients. J Pain Symptom Manage 2000;20:326334.
11. Hamilton KW, Fishman NO. Antimicrobial stewardship interventions: thinking inside and outside the box. Infect Dis Clin North Am 2014;28:301313.
12. D’Agata E, Mitchell S. Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med 2008;168:357362.
13. Chun ED, Rodgers PE, Vitale CA, Collins CD, Malani PN. Antimicrobial use among patients receiving palliative care consultation. Am J Hosp Palliat Care 2010;27:261265.
14. Furuno JP, Noble BN, Horne KN, et al. Frequency of outpatient antibiotic prescription on discharge to hospice care. Antimicrob Agents Chemother 2014;58:54735477.
15. Reinbolt RE, Shenk AM, White PH, Navari RM. Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Symptom Manage 2005;30:175182.
16. Albrecht JS, McGregor JC, Fromme EK, Bearden DT, Furuno JP. A nationwide analysis of antibiotic use in hospice care in the final week of life. J Pain Symptom Manage 2013;46:483490.
17. Metlay JP, Shea JA, Crossette LB, Asch DA. Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients. J Gen Intern Med 2002;17:8794.
18. Marcus EL, Clarfield AM, Moses AE. Ethical issues relating to the use of antimicrobial therapy in older adults. Clin Infect Dis 2001;33:16971705.
19. Leibovici L, Paul M. Ethical dilemmas in antibiotic treatment: focus on the elderly. Clin Microbiol Infect 2015;21:2729.
20. Leibovici L, Paul M, Ezra O. Ethical dilemmas in antibiotic treatment. J Antimicrob Chemother 2012;67:1216.
21. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377381.
22. Huberman AM, Miles MB. Qualitative Data Analysis: An Expanded Sourcebook. 2nd ed. Thousand Oaks, CA: SAGE; 1994.
23. Buss MK, Rock LK, McCarthy EP. Understanding palliative care and hospice: a review for primary care providers. Mayo Clin Proc 2017;92:280286.
24. Rodríguez-Prat A, Monforte-Royo C, Porta-Sales J, Escribano X, Balaguer A. Patient perspectives of dignity, autonomy and control at the end of life: systematic review and meta-ethnography. PLoS One 2016;11(3):e0151435.
25. Rosenberg JH, Albrecht JS, Fromme EK, et al. Antimicrobial use for symptom management in patients receiving hospice and palliative care: a systematic review. J Palliat Med 2013;16:15681574.
26. Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016;63(5):e61e111.
27. Barry MJ, Edgman-Levitan S. Shared decision making—the pinnacle of patient-centered care. N Engl J Med 2012;366:780781.
28. AAP Committee on Hospital Care. Family-centered care and the pediatrician’s role. Pediatrics 2003;112:691696.
29. McCaffrey N, Bradley S, Ratcliffe J, Currow DC. What aspects of quality of life are important from palliative care patients’ perspectives? A systematic review of qualitative research. J Pain Symptom Manage 2016;52:318328.
30. Bakitas M, Lyons KD, Hegel MT, Ahles T. Oncologists’ perspectives on concurrent palliative care in an NCI-designated comprehensive cancer center. Palliat Support Care 2013;11:415423.
31. Snow CE, Varela BR, Pardi DA, Adelman RD, Said S, Reid MC. Identifying factors affecting utilization of an inpatient palliative care service: a physician survey. J Palliat Med 2009;12:231237.
32. Garau J. Impact of antibiotic restrictions: the ethical perspective. Clin Microbiol Infect 2006;12(Suppl 5):1624.
33. Charani E, Castro-Sánchez E, Holmes A. The role of behavior change in antimicrobial stewardship. Infect Dis Clin North Am 2014;28:169175.
34. Charani E, Castro-Sanchez E, Sevdalis N, et al. Understanding the determinants of antimicrobial prescribing within hospitals: the role of “prescribing etiquette. Clin Infect Dis 2013;57:188196.
35. Skodvin B, Aase K, Charani E, Holmes A, Smith I. An antimicrobial stewardship program initiative: a qualitative study on prescribing practices among hospital doctors. Antimicrob Resist Infect Control 2015;4:24.
36. Jin J. Clinicians examine advances and challenges in improving quality of end-of-life care in the ICU. JAMA 2013;310:24932495.
37. Larochelle MR, Rodriguez KL, Arnold RM, Barnato AE. Hospital staff attributions of the causes of physician variation in end-of-life treatment intensity. Palliat Med 2009;23:460470.
38. Baumrucker S, Stolick M, Oertli KA, et al. Aggressive treatment at end of life. Am J Hosp Palliat Med 2016;33:703709.
39. Bachmann LM, Mühleisen A, Bock A, ter Reit G, Held U, Kessels AG. Vignette studies of medical choice and judgement to study caregivers’ medical decision behaviour: systematic review. BMC Med Res Methodol 2008;8(50): doi: 10.1186/1471-2288-8-50.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×
Type Description Title
PDF
Supplementary materials

Gaw et al. supplementary material 1
Gaw et al. supplementary material

 PDF (156 KB)
156 KB
WORD
Supplementary materials

Gaw et al. supplementary material 2
Gaw et al. supplementary material

 Word (106 KB)
106 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 10
Total number of PDF views: 37 *
Loading metrics...

Abstract views

Total abstract views: 172 *
Loading metrics...

* Views captured on Cambridge Core between 12th February 2018 - 18th February 2018. This data will be updated every 24 hours.